Cristina R. Antonescu

The landscape of somatic copy-number alteration across human cancers

Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks

Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trial

NCCN Task Force Report: Update on the Management of Patients with Gastrointestinal Stromal Tumors

Crizotinib in<i>ALK</i>-Rearranged Inflammatory Myofibroblastic Tumor

Acquired Resistance to Imatinib in Gastrointestinal Stromal Tumor Occurs Through Secondary Gene Mutation

Identification of recurrent NAB2-STAT6 gene fusions in solitary fibrous tumor by integrative sequencing

Primary and Secondary Kinase Genotypes Correlate With the Biological and Clinical Activity of Sunitinib in Imatinib-Resistant Gastrointestinal Stromal Tumor

Clinicopathologic correlates of solitary fibrous tumors

Nivolumab with or without ipilimumab treatment for metastatic sarcoma (Alliance A091401): two open-label, non-comparative, randomised, phase 2 trials

Subtype-specific genomic alterations define new targets for soft-tissue sarcoma therapy

Histologic Subtype and Margin of Resection Predict Pattern of Recurrence and Survival for Retroperitoneal Liposarcoma